Literature DB >> 27051395

Manual Lymphatic Drainage after Subepidermal Tracer Injection Optimizes Results of Sentinel Lymph Node Labeling in Primary Breast Cancer.

Martin Sillem1, Urban Bromberger2, Barbara Heitzelmann3, Wolfgang J Brauer2, Martin Werner4, Sylvia Timme4.   

Abstract

INTRODUCTION: Our aim was to assess the practicability and reliability of a novel labeling regime for axillary sentinel lymph nodes (SLNs) in early breast cancer.
METHODS: 362 patients with early breast cancer (bilateral in 9 cases, giving a total of 371 cases) underwent intradermal radio tracer injection with simultaneous manual lymphatic drainage. SLN biopsy was performed within 24 h. For retrospective analysis, data were extracted from patient's records.
RESULTS: At least 1 SLN was detected intraoperatively in 369 cases (99.5%, range 1-9 nodes). This node was metastatic in 88 and unaffected in 281 cases. Coincidentally removed but unlabeled lymph nodes were affected in 3 cases in which the SLN was unaffected (3/153 = 2%). In all cases, on histological evaluation, tissue removed as SLN contained lymph nodes. After a period of 69.5 months (median 1.7-115.8 months), no axillary recurrences were observed in 213 patients.
CONCLUSION: Manual lymphatic drainage is a simple technique that leads to an extremely high pick-up rate of axillary SLNs after subepidermal radio tracer injection. If unaffected, this node correctly predicts nodal-negative disease in 98% of cases studied.

Entities:  

Keywords:  Breast cancer; Manual lymphatic drainage; Sentinel node

Year:  2015        PMID: 27051395      PMCID: PMC4813651          DOI: 10.1159/000442727

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  24 in total

Review 1.  Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance.

Authors:  Marjolein L Smidt; Caroline M M Janssen; Deborah M Kuster; Erik D M Bruggink; Luc J A Strobbe
Journal:  Ann Surg Oncol       Date:  2005-01       Impact factor: 5.344

2.  Anaphylaxis during anesthesia in France: an 8-year national survey.

Authors:  Paul Michel Mertes; François Alla; Philippe Tréchot; Yves Auroy; Eric Jougla
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

3.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

4.  Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.

Authors:  Anees Chagpar; Robert C Martin; Celia Chao; Sandra L Wong; Michael J Edwards; Todd Tuttle; Kelly M McMasters
Journal:  Arch Surg       Date:  2004-06

5.  Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial.

Authors:  David N Krag; Takamaru Ashikaga; Seth P Harlow; Joan M Skelly; Thomas B Julian; Ann M Brown; Donald L Weaver; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2009-08-24       Impact factor: 13.506

6.  How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping?

Authors:  Ramin Sadeghi; Mohammad Naser Forghani; Bahram Memar; Mohammad Taghi Rajabi Mashhadi; Vahid Reza Dabbagh Kakhki; Abbas Abdollahi; Seyed Rasoul Zakavi
Journal:  Ann Nucl Med       Date:  2009-07-09       Impact factor: 2.668

7.  What is a sentinel node and what is a false-negative sentinel node?

Authors:  Omgo E Nieweg; Susanne H Estourgie
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

8.  How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer?

Authors:  Eun Jeong Ban; Jun Sang Lee; Ja Seung Koo; Seho Park; Seung Il Kim; Byeong-Woo Park
Journal:  J Breast Cancer       Date:  2011-12-27       Impact factor: 3.588

9.  Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy.

Authors:  Margaret I Liang; William E Carson
Journal:  World J Surg Oncol       Date:  2008-07-27       Impact factor: 2.754

10.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.